Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing
Amount Raised
$100 Million
Round Type
Series B
WalthamBiotechnologyHealth CareTherapeuticsDescription
Xilio Therapeutics, a company developing potent, tumor-selective immuno-oncology (IO) therapies for patients with cancer, today announced the closing of a $100.5 million Series B financing. Proceeds from the financing will be used to progress Xilio’s first two therapeutic candidates, XTX201 (tumor-selective IL-2) and XTX101 (tumor-selective aCTLA4 mAb) through Investigational New Drug (IND) enabling studies and into Phase 1 clinical trials, as well as advance additional tumor-selective cytokine programs using Xilio’s proprietary technology.
Quick answer
Xilio Therapeutics raised $100 Million in a Series B round, dated March 2, 2020. Xilio Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Xilio Therapeutics raise?
- Xilio Therapeutics raised $100 Million in a Series B round on March 2, 2020.
- What does Xilio Therapeutics do?
- Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer.
- Where is Xilio Therapeutics based and how big is it?
- Xilio Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 88 employees.
- Who are the decision-makers at Xilio Therapeutics?
- Fundz holds 1 contact at Xilio Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Xilio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Phio Pharmaceuticals raised $4.4M on April 14, 2020.
- Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
- Legend Biotech raised $150M on April 7, 2020.
- Vaxcyte, Inc. raised $110M on April 3, 2020.
- Windtree Therapeutics raised an undisclosed amount (Grant) on March 31, 2020.
- Dyne Therapeutics raised an undisclosed amount on March 31, 2020.
Who to call at Xilio Therapeutics, and when
A new round usually means Xilio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Xilio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xilio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xilio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xilio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansXilio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.